SuperworthAdial Pharmaceuticals market cap ADIL
Share price times shares outstanding: what the whole company sells for, since 2018.
- Today, Oct 23, 2026
- $10.3M
- Highest close in our data
- $94M
- Sep 2021
Adial Pharmaceuticals is worth $10.3M at the close on Oct 23, 2026, at $3.92 a share.
That is up 31% over the last year and down 84% over five years.
Its highest close in our data was $94M in Sep 2021.
Market cap over time
Year by year
| Year | End of year | Low | High | Change |
|---|---|---|---|---|
| 2026 so far | $10.3M | $2M | $18.7M | +87% |
| 2025 | $5.5M | $2M | $8.7M | −16% |
| 2024 | $6.5M | $1M | $9.4M | +188% |
| 2023 | $2.3M | $2.1M | $13.4M | −62% |
| 2022 | $5.9M | $5.9M | $54.4M | −89% |
| 2021 | $56.1M | $27.3M | $94M | +132% |
| 2020 | $24.2M | $12.4M | $29.3M | −4% |
| 2019 | $25.3M | $14.6M | $45.7M | −31% |
| 2018 | $36.4M | $8.7M | $36.4M | n/a |
Against its peers
Companies in Drug Manufacturers - General nearest Adial Pharmaceuticals' size, closest first, today.
| Company | Market cap |
|---|---|
| ADILAdial Pharmaceuticals | $10.3M |
| ATNMActinium Pharmaceuticals | $47.8M |
| SPROSpero Therapeutics | $64.6M |
| LFVNLifevantage | $73.4M |
| Peer median | $64.6M |
What the market cap tells you
Share price times shares outstanding: what the whole company sells for today.
Size, not quality. Large caps move slower and are covered more. That is all it tells you.
More on Adial Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.